Engineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners

Org Lett. 2010 Apr 16;12(8):1744-7. doi: 10.1021/ol100342m.

Abstract

Platensimycin (1) and platencin (2) are novel antibiotic leads against multidrug resistant pathogens. The production of 2 in Streptomyces platensis MA7339 is under the control of ptnR1, a GntR-like transcriptional regulator. Inactivating ptnR1 afforded S. platensis MA7339 mutant strain SB12600 that overproduces 2 at a titer approximately 100-fold greater than that from the wild-type strain and accumulates platencin A(1) (3) and eight new congeners, platencins A(2)-A(9) (4-11). The isolation, structural elucidation, and antibacterial activity of 4-11, in comparison to 1-3, are described.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminophenols / chemistry*
  • Aminophenols / isolation & purification
  • Aminophenols / metabolism*
  • Aminophenols / pharmacology
  • Anti-Bacterial Agents / biosynthesis*
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology
  • Genetic Engineering / methods*
  • Microbial Sensitivity Tests
  • Polycyclic Compounds / chemistry*
  • Polycyclic Compounds / isolation & purification
  • Polycyclic Compounds / metabolism*
  • Polycyclic Compounds / pharmacology
  • Staphylococcus aureus / drug effects
  • Streptomyces / genetics*
  • Streptomyces / metabolism*

Substances

  • Aminophenols
  • Anti-Bacterial Agents
  • Polycyclic Compounds
  • platencin